Treatment of obsessive-compulsive disorder with fluvoxamine: A multicentre, double-blind, placebo-controlled trial

International Clinical Psychopharmacology

Volumn 11, Issue 1, 1996, Pages 21-29

  Goodman, W K ^a   Kozak, M J ^b   Liebowitz, M ^c   White, K L ^d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

fluvoxamine; obsessive compulsive disorder; selective serotonin reuptake inhibitors

Indexed keywords

FLUVOXAMINE; PLACEBO;

ADULT; ANORGASMIA; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NERVOUSNESS; OBSESSION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE;

EID: 0029925952     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199603000-00003     Document Type: Article

References (39)

1. Amin MM, Ananth JV, Coleman BS, Darcourt G, Farkas T, Goldstein B, Lapierre YD, Paykel E and Wakelin JS (1984) Fluvoxamine: antidepressant effects confirmed in a placebo-controlled international study. Clinical Neuropharmacology, 7(Suppl), 312-319.
2. Ananth J, Pecknold JC, van den Steen N and Engelsmann F (1981) Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Progress in Neuropsychopharmacology, 5, 257-262.
3. Apter A, Pauls DL, Bleich A, Zohar AH, Kron S, Ratzoni G, Dycian A, Kotler M, Weizman A, Gadot N and Cohen DJ (1993) An epidemiologic study of Gilles de la Tourette's syndrome in Israel. Archives of General Psychiatry, 50, 734-738.
4. Benfield P and Ward A (1986) Fluvoxamine, a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs, 32, 313-334.
5. Blier P, Mansari ME and Bouchard C (1994) Alteration of serotonin release in the orbito-frontal cortex by paroxetine: relevance to obsessive - compulsive disorder. Presented at the Annual Meeting of the American College of Neuropsychopharmacology.
6. Burton SW (1991) A review of fluvoxamine and its uses in depression. International Clinical Psychopharmacology, 6, 1-21.
7. Conti L, Dell'osso L, Re F, Musetti L and Cassano GB (1988) Fluvoxamine: double-blind clinical trial vs placebo in hospitalised depressed patients. Current Therapeutic Research, 43, 468-480.
8. De Veaugh-Geiss J, Landau P and Katz R (1989) Treatment of obsessive-compulsive disorder with clomipramine. Psychiatric Annals, 19, 97-101.
9. Feighner JP, Boyer WF, Meredith CH and Hendrickson GG (1989) A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression. International Clinical Psychopharmacology, 4, 239-244.
10. Foa EB (1979) Failure in treating obsessive-compulsive disorder. Behaviour Research and Therapy, 17, 169-176.
11. Freeman CPL, Trimble MR, Deakin JFW, Stokes TM and Ashford JJ (1994) Fluvoxamine versus clomipramine in the treatment of obsessive-compulsive disorder? A multicenter, randomized, double-blind, parallel-group comparison. Journal of Clinical Psychiatry, 55, 301-305.
12. Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR and Charney DS (1989a) Efficacy of fluvoxamine in obsessive-compulsive disorder. Archives of General Psychiatry, 46, 36-44.
13. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR and Charney DS (1989b) The Yale-Brown Obsessive-Compulsive Scale. I: Development, use, reliability. Archives of General Psychiatry, 46, 1006-1011.
14. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR and Charney DS (1989c) The Yale-Brown Obsessive-Compulsive Scale. II: Validity. Archives of General Psychiatry, 46, 1012-1016.
15. Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR and Charney DS (1990) Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Archives of General Psychiatry, 47, 577-585.
16. Goodman WK, McDougle CJ and Price LH (1992) Pharmacotherapy of obsessive compulsive disorder. Journal of Clinical Psychiatry, 53(Suppl), 29-37.
17. Guy W (1976) ECDEU Assessment Manual for Psychopharmacology. National Institute of Mental Health: US Department of Health, Education and Welfare, Washington, DC.
18. Hamilton M (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278-296.
19. Insel TR, Murphy DL, Cohen RM, Alterman I, Kilts C and Linnoila M (1983) Obsessive compulsive disorder: a double-blind trial of clomipramine and clorgyline. Archives of General Psychiatry, 40, 605-612.
20. Insel TR, Mueller EA, Alterman I, Linnoila M and Murphy DL (1985) Obsessive-compulsive disorder and serotonin: is there a connection? Biological Psychiatry, 20, 1174-1188.
21. Jenike MA (1990) Drug treatment of obsessive-compulsive disorder. In: Obsessive-Compulsive Disorders: Theory and Management (Eds MA Jenike, L Baer and WE Minichiello), Year Book Medical Publishers, Littleton, MA.
22. Jenike MA, Hyman S, Baer L, Holland A, Minichiello WE, Buttolph L, Summergrad P, Seymour R and Ricciardi J (1990) A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. American Journal of Psychiatry, 147, 1209-1215.
23. Karno M, Goldin JM, Sorenson SB and Burnam MA (1988) The epidemiology of obsessive-compulsive disorder in five US communities. Archives of General Psychiatry, 45, 1094-1099.
24. Leonard HL, Swedo SE, Rapoport JL, Coffey M and Cheslow D (1988) Treatment of childhood obsessive-compulsive disorder with clorimipramine and desipramine: a double-blind crossover comparison. Psychopharmacology Bulletin, 24, 93-95.
25. Leonard HL, Swedo SE, Lenane MC, Rettew DC, Cheslow DL, Hamburger SD and Rapoport JL (1991) A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder. Archives of General Psychiatry, 48, 922-927.
26. March JS, Kobak KA, Jefferson JW, Mazza J and Greist JH (1990) A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression. Journal of Clinical Psychiatry, 51, 200-202.
27. McDougle CJ, Goodman WK and Price LH (1994) Dopamine antagonists in tic-related and psychotic spectrum obsessive-compulsive disorder. Journal of Clinical Psychiatry, 55(Suppl), 24-31.
28. McTavish D and Benfield P (1990) Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive-compulsive disorder. Drugs. 39, 136-153.
29. Montgomery SA (1980) Clomipramine in obsessional neurosis: a placebo-controlled trial. Pharmaceutical Medicine, 1, 189-192.
30. Montgomery SA and Manceaux A (1992) Fluvoxamine in the treatment of obsessive-compulsive disorder. International Clinical Psychopharmacology, 7(Suppl 1), 5-9.
31. Perse T, Greist JH, Jefferson JW, Rosenfeld R and Dar R (1987) Fluvoxamine treatment of obsessive-compulsive disorder. American Journal of Psychiatry, 144, 1543-1548.
32. Price LH, Goodman WK, Charney DS, Rasmussen SA and Heninger GR (1987) Treatment of severe obsessive-compulsive disorder with fluvoxamine. American Journal of Psychiatry, 144, 1059-1061.
33. Rasmussen SA and Tsuang MT (1984) The epidemiology of obsessive-compulsive disorder. Journal of Clinical Psychiatry, 45, 450-457.
34. Smeraldi E, Erzegovesi S, Bianchi I and Pasquali L (1992) Fluvoxamine versus clomipramine treatment in obsessive-compulsive disorder: a preliminary study. New Trends in Experimental and Clinical Psychiatry, 8, 63-65.
35. Tamimi RR, Mavissalian MR, Jones B and Olson S (1991) Clomipramine versus fluvoxamine in obsessive compulsive disorder. Annals of Clinical Psychiatry, 3, 275-279.
36. Thoren P, Asberg M, Cronholm B, Jornestedt L and Traskman L (1980) Clomipramine treatment in obsessive-compulsive disorder. Archives of General Psychiatry, 37, 1281-1285.
37. Towbin KE, Leckman JF and Cohen DJ (1987) Drug treatment of obsessive-compulsive disorder: a review of findings in the light of diagnostic and metric limitations. Psychiatric Developments, 1, 25-50.
38. Wagner W, Plekkenpol B, Gray TE, Vlaskamp H and Essers H (1993) Safety database on fluvoxamine: analysis and report. Pharmacopsychiatry, 26(Suppl), 10-16.
39. Zohar J and Insel TR (1987) Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment and pathophysiology. Biological Psychiatry, 22, 667-687.